BW VACCINE SURGE MEETING

File: 110596_sep96_decls14_0001.txt
Page: 0001
Total Pages: 3

Subject: BW VACCINE SURGE MEETING                                        

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: BW VACCINE SURGE MEETING                                                                        

Document Number:          1

Folder SEQ  #:         10








                                                              UNCLASSIFIED



         DASG-PSZ



         MEMORANDUM FOR RECORD

         SUBJECT: BW Vaccine Surge Meeting

         1. A meeting was held 18 December 1990 at Fort Detrick, Maryland
         with members of the working group for the Industrial Surge of BW
         vaccines and antitoxin. The meeting was chaired by the
         undersigned with the new commander of Medical Research and
         Development Command, MG Richard T. Travis in attendance. Other
         representatives from HQ, MRDC, MRDC Contracting, USARRIID and
         the Office of the Chief of the Veterinary Corps, OTSG, were
         present.

         2. Updates were provided as followed:

             A. Michigan Public Health Department. The contract to
         produce increased amounts of anthrax vaccine is operative
         and the testing for FDA licensure referred to in earlier memoranda
         continues. Assuming no difficulties with FDA the increased
         production should commence early in February.

             B. Lederle-Praxis. The company has begun hiring and will
         begin immunizing personnel this week. They have still not
         submitted a final cost proposal, although it is expected this
         week (at which time a letter contract will be provided to them to
         do whatever is necessary to begin production). It has been
         determined that, although they are producing a known vaccine, since
         it is a new facility they must undergo FDA licensure testing
         which may delay the onset of production to 1 April. Since the
         original goal was 15 February, this was not acceptable. Ways to
         expedite the onset of production were explored. The need for a
         chilling tank was recognized and MRDC will help them in procuring
         it. They also could begin production earlier if licensuret
         standards were not met (which will mean that the drug will be in
ted to do that if the time for
         licensure could not be shortened. The company is enthusiastic and
         supportive and will do things in parallel so that production will
         begin as soon as possible, with the middle of February still being
         the goal.

                        DECLASSIFIED
                        ON: 29 OCT 96
                        BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958





          UNCLASSIFIED

Document 3 f:/Week-36/BX003202/BW VACCINE SURGE MEETING/bw vaccine surge meeting:11049609101515
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = BW VACCINE SURGE MEETING
Folder Seq # = 10
Subject = BW VACCINE SURGE MEETING
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 04-NOV-1996